Gender disparities in time-to-initiation of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: a nationwide cohort study

被引：0
|
作者：
Funck, K. L. [1 ]
Bjerg, L. [1 ]
Isaksen, A. A. [1 ]
Sandbaek, A. [1 ]
Grove, E. L. [2 ]
机构：
[1] Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Cardiol, Aarhus N, Denmark
来源：
DIABETOLOGIA | 2022年 / 65卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
336
引用
收藏
页码：S176 / S176
页数：1
相关论文
共 50 条
  • [41] Concomitant use of benzodiazepines and oral glucose-lowering drugs in patients with type-2 diabetes
    Fornero, Agostina
    Bertoldo, Pamela
    Dumont, Nilda
    FARMACEUTICOS COMUNITARIOS, 2018, 10 (01): : 41 - 46
  • [42] Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes
    Chen, Wei-Han
    Li, Yujia
    Yang, Lanting
    Allen, John M.
    Shao, Hui
    Donahoo, William T.
    Billelo, Lori
    Hu, Xia
    Shenkman, Elizabeth A.
    Bian, Jiang
    Smith, Steven M.
    Guo, Jingchuan
    PLOS ONE, 2024, 19 (01):
  • [43] Cardiovascular prevention in type 2 diabetes mellitus patients: the role of oral glucose-lowering agents
    Anselmino, Matteo
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2009, 23 (06) : 427 - 433
  • [44] Differences In Risk of Death according to Type of Oral Glucose-lowering Therapy In Patients with Diabetes: A Nationwide Study
    Schramm, Tina Ken
    Gislason, Gunnar H.
    Rasmussen, Soren
    Jorgensen, Casper H.
    Folke, Fredrik
    Hansen, Morton L.
    Fosbol, Emil L.
    Bretler, Ditte-Marle
    Kober, Lars
    Vaag, Alfan
    Torp-Pedersen, Christian
    CIRCULATION, 2008, 118 (18) : S1117 - S1117
  • [45] Association study of six type 2 diabetes genes and glucose-lowering effect of sulfonylurea drugs
    Schroner, Z.
    Javorsky, M.
    Klimcakova, L.
    Dobrikova, M.
    Habalova, V.
    Babjakova, E.
    Zidzik, J.
    Fabianova, M.
    Slaba, E.
    Kozarova, M.
    Tkacova, R.
    Salagovic, J.
    Tkac, I.
    DIABETOLOGIA, 2011, 54 : S123 - S123
  • [46] Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes
    Preiser, Jean-Charles
    Provenzano, Bruna
    Mongkolpun, Wasineeart
    Halenarova, Katarina
    Cnop, Miriam
    ANESTHESIOLOGY, 2020, 133 (02) : 430 - 438
  • [47] Glucose-Lowering Drugs and Risk of COPD Exacerbations in Adults with Type 2 Diabetes
    Ray, Avik
    Paik, Julie M.
    Feldman, William B.
    Sreedhara, Sushama Kattinakere
    Wexler, Deborah J.
    Patorno, Elisabetta
    DIABETES, 2024, 73
  • [48] Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
    Patti, Angelo Maria
    Rizvi, Ali A.
    Giglio, Rosaria Vincenza
    Stoian, Anca Pantea
    Ligi, Daniela
    Mannello, Ferdinando
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [49] Incidence of depression in patients with cardiovascular disease and type 2 diabetes: a nationwide cohort study
    Zareini, Bochra
    Sorensen, Katrine Kold
    Blanche, Paul
    Falkentoft, Alexander C.
    Fosbol, Emil
    Kober, Lars
    Torp-Pedersen, Christian
    CLINICAL RESEARCH IN CARDIOLOGY, 2024, 113 (11) : 1523 - 1533
  • [50] Combined use of cardioprotective glucose-lowering drugs and statins in individuals with type 2 diabetes is associated with the lowest risk of allcause mortality
    Ternhamar, Tummas
    Johansen, Mia
    Nordestgaard, Borge
    Afzal, Shoaib
    CIRCULATION, 2024, 150
12345